Literature DB >> 32531337

Ion channel formation by N-terminally truncated Aβ (4-42): relevance for the pathogenesis of Alzheimer's disease.

Abhijith G Karkisaval1, Agueda Rostagno2, Rustam Azimov3, Deependra K Ban1, Jorge Ghiso4, Bruce L Kagan5, Ratnesh Lal6.   

Abstract

Aβ deposition is a pathological hallmark of Alzheimer's disease (AD). Besides the full-length amyloid forming peptides (Aβ1-40 and Aβ1-42), biochemical analyses of brain deposits have identified a variety of N- and C-terminally truncated Aβ variants in sporadic and familial AD patients. However, their relevance for AD pathogenesis remains largely understudied. We demonstrate that Aβ4-42 exhibits a high tendency to form β-sheet structures leading to fast self-aggregation and formation of oligomeric assemblies. Atomic force microscopy and electrophysiological studies reveal that Aβ4-42 forms highly stable ion channels in lipid membranes. These channels that are blocked by monoclonal antibodies specifically recognizing the N-terminus of Aβ4-42. An Aβ variant with a double truncation at phenylalanine-4 and leucine 34, (Aβ4-34), exhibits unstable channel formation capability. Taken together the results presented herein highlight the potential benefit of C-terminal proteolytic cleavage and further support an important pathogenic role for N-truncated Aβ species in AD pathophysiology.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amyloid; Electrophysiology; Oligomers; Truncated Aβ peptides

Mesh:

Substances:

Year:  2020        PMID: 32531337      PMCID: PMC8132454          DOI: 10.1016/j.nano.2020.102235

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  54 in total

1.  Aβ truncated species: Implications for brain clearance mechanisms and amyloid plaque deposition.

Authors:  Erwin Cabrera; Paul Mathews; Emiliya Mezhericher; Thomas G Beach; Jingjing Deng; Thomas A Neubert; Agueda Rostagno; Jorge Ghiso
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-07-13       Impact factor: 5.187

Review 2.  Animal models of Alzheimer's disease and drug development.

Authors:  Bart Laurijssens; Fabienne Aujard; Anisur Rahman
Journal:  Drug Discov Today Technol       Date:  2013-09

3.  Native Ion Mobility-Mass Spectrometry Reveals the Formation of β-Barrel Shaped Amyloid-β Hexamers in a Membrane-Mimicking Environment.

Authors:  Nicklas Österlund; Rani Moons; Leopold L Ilag; Frank Sobott; Astrid Gräslund
Journal:  J Am Chem Soc       Date:  2019-06-19       Impact factor: 15.419

4.  Nanodisc-Forming Scaffold Protein Promoted Retardation of Amyloid-Beta Aggregation.

Authors:  Bikash Ranjan Sahoo; Takuya Genjo; Sarah J Cox; Andrea K Stoddard; G M Anantharamaiah; Carol Fierke; Ayyalusamy Ramamoorthy
Journal:  J Mol Biol       Date:  2018-08-28       Impact factor: 5.469

5.  Effects of solvent on the structure of the Alzheimer amyloid-beta(25-35) peptide.

Authors:  Guanghong Wei; Joan-Emma Shea
Journal:  Biophys J       Date:  2006-06-09       Impact factor: 4.033

Review 6.  Amyloid peptide channels.

Authors:  B L Kagan; R Azimov; R Azimova
Journal:  J Membr Biol       Date:  2004-11       Impact factor: 1.843

7.  Alzheimer's amyloid-beta intermediates generated using polymer-nanodiscs.

Authors:  Bikash R Sahoo; Takuya Genjo; Michael Bekier; Sarah J Cox; Andrea K Stoddard; Magdalena Ivanova; Kazuma Yasuhara; Carol A Fierke; Yanzhuang Wang; Ayyalusamy Ramamoorthy
Journal:  Chem Commun (Camb)       Date:  2018-11-13       Impact factor: 6.222

8.  Activity and architecture of pyroglutamate-modified amyloid-β (AβpE3-42) pores.

Authors:  Alan L Gillman; Hyunbum Jang; Joon Lee; Srinivasan Ramachandran; Bruce L Kagan; Ruth Nussinov; Fernando Teran Arce
Journal:  J Phys Chem B       Date:  2014-06-24       Impact factor: 2.991

9.  In vivo Differential Brain Clearance and Catabolism of Monomeric and Oligomeric Alzheimer's Aβ protein.

Authors:  Farron L McIntee; Patrizia Giannoni; Steven Blais; George Sommer; Thomas A Neubert; Agueda Rostagno; Jorge Ghiso
Journal:  Front Aging Neurosci       Date:  2016-09-27       Impact factor: 5.750

10.  Diversity of Amyloid-beta Proteoforms in the Alzheimer's Disease Brain.

Authors:  Norelle C Wildburger; Thomas J Esparza; Richard D LeDuc; Ryan T Fellers; Paul M Thomas; Nigel J Cairns; Neil L Kelleher; Randall J Bateman; David L Brody
Journal:  Sci Rep       Date:  2017-08-25       Impact factor: 4.379

View more
  1 in total

1.  N-terminally truncated Aβ4-x proteoforms and their relevance for Alzheimer's pathophysiology.

Authors:  Agueda Rostagno; Erwin Cabrera; Tammaryn Lashley; Jorge Ghiso
Journal:  Transl Neurodegener       Date:  2022-06-01       Impact factor: 9.883

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.